Video Game-based Therapy for Arm Weakness In Progressive Multiple Sclerosis

April 16, 2019 updated by: Lynne Gauthier, University of Massachusetts, Lowell
Participants will receive intensive therapy through a video game in their own homes for 1 month. The game is operated by movements of the body (no controller needed) and acts like a virtual therapist. Participants will agree to play the game for 30 hours. They will also receive 4 home visits from a therapist designed to increase use of their arm for daily activities that are important to them. Participants will also receive a smart watch that will measure use of their weaker arm and alert them when their arm is not participating in activities. Arm strength and function will be measured before and after the therapy program.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Randomized waitlist control trial. One group will receive treatment immediately (50%) and the other group will receive treatment following a three-week delay (50%). Group 1 will be assessed by physical/occupational therapists and rehabilitation psychologists (blinded to treatment phase) before and after the virtual gaming treatment. Group 2 will receive two baseline assessments (baseline followed by three weeks of usual and customary care and then another baseline before starting the gaming treatment), and again after three weeks of virtual gaming treatment.

Study Type

Interventional

Enrollment (Actual)

31

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Columbus, Ohio, United States, 43210
        • The Ohio State University, 2154 Dodd Hall

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients who have progressive multiple sclerosis resulting in upper extremity motor impairment.
  • Have the ability to comprehend and participate in basic elements of the therapy.
  • Have substantial non-use in the more affected upper extremity.

Exclusion Criteria:

  • Are currently participating in other experimental trials.
  • Are currently participating in additional upper extremity therapy.
  • Experienced relapse within the past 6 months.
  • Too frail to undergo intensive rehabilitation,
  • Those with serious, uncontrolled medical problems.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Immediate Treatment

Patients will receive an in-home consultation with an occupational/physical therapist in which they are educated about the intervention, the system is set up, and they are guided through use of the system. After initial contact, therapist support will be available via telephone to address specific difficulties with operating the system, as well as three additional home visits throughout the 3 week intervention.

The rehabilitation program requires use of the rehabilitation gaming system for 1.5 hours daily for 21 consecutive days (equivalent dosage to standard CI therapy), limb activation device worn for 90% of waking hours, and completion of the automated transfer package to facilitate real-world arm use (e.g., problem-solving modules, daily monitoring of arm use). After completing the intervention, the patient will receive additional consultation with the therapist to formulate goals for follow-up. Follow-up assessments will be conducted to assess long-term retention of motor gains.

Intensive remote (via video game) therapy for upper extremity hemiparesis.
ACTIVE_COMPARATOR: Delayed Treatment

Patients will receive an in-home consultation with an occupational/physical therapist in which they are educated about the intervention, the system is set up, and they are guided through use of the system. After initial contact, therapist support will be available via telephone to address specific difficulties with operating the system, as well as three additional home visits throughout the 3 week intervention.

The rehabilitation program requires use of the rehabilitation gaming system for 1.5 hours daily for 21 consecutive days (equivalent dosage to standard CI therapy), limb activation device worn for 90% of waking hours, and completion of the automated transfer package to facilitate real-world arm use (e.g., problem-solving modules, daily monitoring of arm use). After completing the intervention, the patient will receive additional consultation with the therapist to formulate goals for follow-up. Follow-up assessments will be conducted to assess long-term retention of motor gains.

Intensive remote (via video game) therapy for upper extremity hemiparesis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bilateral Activity Monitors (Accelerometers)
Time Frame: 0 to 1 Months
Devices to monitor upper extremity movement throughout treatment
0 to 1 Months
Wolf Motor Function Test
Time Frame: 0 to 1 Months
Assessment to evaluate motor function
0 to 1 Months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Biomechanical Measures
Time Frame: 0 to 1 Months
Recorded during game play through limb activation device and Kinect
0 to 1 Months
Multiple Sclerosis Impact Scale (MSIS-29)
Time Frame: 0 to 1 Months
Scale to asses living with MS
0 to 1 Months
Short form-36 Health Survey
Time Frame: 0 to 1 Months
Survey
0 to 1 Months
Neuro-QOL
Time Frame: 0 to 1 Months
Assessment to measure quality of life
0 to 1 Months
Patient Health Questionnaire (PHQ-9)
Time Frame: 0 to 1 Months
0 to 1 Months
Montreal Cognitive Assessment (MoCA)
Time Frame: 0 to 1 Months
Assessment to measure cognitive function
0 to 1 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2015

Primary Completion (ACTUAL)

October 31, 2018

Study Completion (ACTUAL)

October 31, 2018

Study Registration Dates

First Submitted

March 23, 2017

First Submitted That Met QC Criteria

March 23, 2017

First Posted (ACTUAL)

March 29, 2017

Study Record Updates

Last Update Posted (ACTUAL)

April 18, 2019

Last Update Submitted That Met QC Criteria

April 16, 2019

Last Verified

April 1, 2019

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemiparesis

Clinical Trials on Gaming CI Therapy

Subscribe